(Q43958113)

28 November 2017

title

Dyspepsia: how should we measure it? (English)

1 reference

28 November 2017

Kuykendall DH

1

1 reference

28 November 2017

Rabeneck L

series ordinal

2

1 reference

28 November 2017

Campbell CJ

series ordinal

3

1 reference

28 November 2017

Wray NP

series ordinal

4

1 reference

28 November 2017

publication date

1 February 1998

1 reference

Journal of Clinical Epidemiology

28 November 2017

published in

1 reference

28 November 2017

volume

51

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

99-106

1 reference

Definition and investigation of dyspepsia. Consensus of an international ad hoc working party

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Definitions of dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Prevalence of symptoms of dyspepsia in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Do young patients with dyspepsia need investigation?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Early detection of gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

The predictive value of history in dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

A systematic overview (meta-analysis) of outcome measures in Helicobacter pylori gastritis trials and functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, nonulcer dyspepsia and Campylobacter-associated gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Pain measurement: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Grading the severity of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Back pain in primary care. Outcomes at 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Symptoms in gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

Responsiveness to change: an aspect of validity, not a separate dimension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2897%2900245-X

7 January 2021

10.1016/S0895-4356(97)00245-X

Identifiers

DOI

1 reference

28 November 2017

1 reference